Skip to content

Demonstrative Research on TCM Diagnostic and Treated Program of Post Infectious Cough

Demonstrative Research on TCM Diagnostic and Treated Program of Post Infectious Cough

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000354
Enrollment
Unknown
Registered
2009-03-29
Start date
2009-04-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cough of post infectious disease

Interventions

A:TCM granule

Sponsors

Guangdong Provincial Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Had ever stuffy nose, runny nose, sneezing, tears, pharyngodynia, cough, sputum, fever and other symptoms of upper respiratory tract infection, persistent cough after infectious symptoms resolving, manifested as irritating dry cough or expectorate a small amount of white sputum; acute tracheo-bronchitis induced by acute upper respiratory tract infection, manifested as expectorate yellow purulent sputum or yellow-white viscous sputum, but infectious symptom has relieved as including; cough duration is from 3-8 weeks; normal chest film; normal pulmonary ventilation function and bronchial provocation test is negative; the proportion of eosinophils of induced sputum cytology=3; Wind-cold Lingering in Lung or Wind-heat Stasis in Lung according to differentiation of syndrome by TCM; age is from 18-65 years old; informed consent.

Exclusion criteria

Exclusion criteria: History of chronic respiratory diseases like asthma, chronic bronchitis, etc; history of chronic heart failure or serious primary disease of other system; postnatal drip or acid reflux, stomachache and so on in usual; smoking or smoking cessation relapse at present; intake ACEI late month; body temperature higher than 37.3 degree C; peripheral white blood cell count>10*10^9/L or<4*10^9/L; lactation, pregnancy or preparing for pregnancy; psychotic; non-cooperation; participate in other clinical trial late month or at present.

Design outcomes

Secondary

MeasureTime frame
Cough sensitivity, airway neurogenic inflammation mediators, number of cough recurrent, effectivenes;Cough sensitivity and airway neurogenic inflammation mediators only detected in subcenter in Guangzhou area;stool routine and occult blood test, hepatic and renal function, electrocardiogram;

Primary

MeasureTime frame
Scoring of cough, time of cough remission, numeric;

Countries

China

Contacts

Public ContactLin Lin
drlinlin620@163.com+86 0 13903002015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026